Home › Companies › JAZZ PHARMACEUTICALS PLC › 2024-2025
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and JAZZ PHARMACEUTICALS PLC’s Form 8-K, filed July 26, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of July 25, 2024: 7 items on JAZZ PHARMACEUTICALS PLC’s Form 8-K, filed July 26, 2024: 4 elected · 3 approved.
No notable dissent.
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore JAZZ PHARMACEUTICALS PLC in the interactive database Compare manager voting policies
These tallies are JAZZ PHARMACEUTICALS PLC’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed July 26, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Laura J. Hamill | 52,774,330 | 1,432,999 | 133,482 | -- | 3,692,565 | 97% | Elected | — |
| Elect Director: Patrick Kennedy | 52,306,399 | 1,901,706 | 132,706 | -- | 3,692,565 | 96% | Elected | — |
| Elect Director: Kenneth W. O'Keefe | 50,931,857 | 3,280,188 | 128,766 | -- | 3,692,565 | 94% | Elected | — |
| Elect Director: Mark D. Smith, M.D. | 50,507,449 | 3,685,604 | 147,758 | -- | 3,692,565 | 93% | Elected | — |
| 2. To ratify, on a non-binding advisory basis, the appointment of KPMG, Dublin as our independent auditors for the fiscal year ending December 31, 2024 and to authorize, in a binding vote, our board of directors, acting through the audit committee, to determin | 56,719,225 | 1,184,200 | 129,951 | -- | -- | 98% | Approved | — |
| 3. To approve, on a non-binding advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement | 49,319,464 | 4,780,265 | 241,082 | -- | 3,692,565 | 91% | Approved | — |
| 5. To grant our board of directors authority under Irish law to allot and issue ordinary shares for cash without first offering those ordinary shares to existing shareholders pursuant to the statutory pre-emption right that would otherwise apply | 52,568,310 | 5,308,898 | 156,168 | -- | -- | 91% | Approved | — |
Source: JAZZ PHARMACEUTICALS PLC, Form 8-K, filed with the SEC on July 26, 2024 — read the filing on EDGAR.
See voting trends for Health Care companies, 2024-2025: shareholder support by sector and by company size.
544 asset managers disclosed a vote on at least one JAZZ PHARMACEUTICALS PLC item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of JAZZ PHARMACEUTICALS PLC’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 4 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Description as filed by funds: To elect four nominees for director named below to hold office until the 2027 Annual General Meeting of Shareholders: Kenneth W. O'Keefe
JAZZ PHARMACEUTICALS PLC’s own tally for this item (“Elect Director: Kenneth W. O'Keefe”): 50,931,857 for, 3,280,188 against, per its Form 8-K filed July 26, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Each of the four nominees for director was elected as follows:”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 121 asset managers below reported 24,026,076 for, 236,488 against, 12,631 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,172,417 | 0 | 0 | 0 | For |
| BlackRock | 3,340,428 | 0 | 0 | 0 | For |
| Capital Group | 2,000,000 | 0 | 0 | 0 | For |
| Fidelity | 1,860,787 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 1,384,214 | 0 | 0 | 0 | For |
| JPMorgan | 1,142,041 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 949,636 | 0 | 0 | 0 | For |
| Dimensional | 723,171 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 587,263 | 0 | 0 | 0 | For |
| Capitol Series Trust | 529,982 | 0 | 0 | 0 | For |
| Pear Tree Funds | 512,200 | 0 | 0 | 0 | For |
| State Street | 495,031 | 0 | 0 | 0 | For |
| Charles Schwab | 451,732 | 0 | 0 | 0 | For |
| Transamerica | 378,261 | 0 | 0 | 0 | For |
| TIAA | 352,728 | 0 | 0 | 0 | For |
| First Trust | 231,775 | 0 | 0 | 0 | For |
| SEI | 224,419 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 211,351 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 200,541 | 0 | 0 | 0 | For |
| Federated Hermes | 192,148 | 0 | 0 | 0 | For |
| John Hancock | 160,308 | 0 | 0 | 0 | For |
| Jackson National | 141,257 | 0 | 0 | 0 | For |
| ETF Series Solutions | 0 | 125,584 | 0 | 0 | Against |
| Equitable | 29,441 | 79,746 | 0 | 0 | Mixed |
| Voya | 90,093 | 0 | 0 | 0 | For |
Showing the 25 largest of 121 asset managers. All 121 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: To elect four nominees for director named below to hold office until the 2027 Annual General Meeting of Shareholders: Laura J. Hamill
JAZZ PHARMACEUTICALS PLC’s own tally for this item (“Elect Director: Laura J. Hamill”): 52,774,330 for, 1,432,999 against, per its Form 8-K filed July 26, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Each of the four nominees for director was elected as follows:”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 121 asset managers below reported 24,261,168 for, 1,396 against, 12,631 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,172,417 | 0 | 0 | 0 | For |
| BlackRock | 3,340,428 | 0 | 0 | 0 | For |
| Capital Group | 2,000,000 | 0 | 0 | 0 | For |
| Fidelity | 1,860,787 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 1,384,214 | 0 | 0 | 0 | For |
| JPMorgan | 1,142,041 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 949,636 | 0 | 0 | 0 | For |
| Dimensional | 723,171 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 587,263 | 0 | 0 | 0 | For |
| Capitol Series Trust | 529,982 | 0 | 0 | 0 | For |
| Pear Tree Funds | 512,200 | 0 | 0 | 0 | For |
| State Street | 495,031 | 0 | 0 | 0 | For |
| Charles Schwab | 451,732 | 0 | 0 | 0 | For |
| Transamerica | 378,261 | 0 | 0 | 0 | For |
| TIAA | 352,728 | 0 | 0 | 0 | For |
| First Trust | 231,775 | 0 | 0 | 0 | For |
| SEI | 224,419 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 211,351 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 200,541 | 0 | 0 | 0 | For |
| Federated Hermes | 192,148 | 0 | 0 | 0 | For |
| John Hancock | 160,308 | 0 | 0 | 0 | For |
| Jackson National | 141,257 | 0 | 0 | 0 | For |
| ETF Series Solutions | 125,584 | 0 | 0 | 0 | For |
| Equitable | 109,187 | 0 | 0 | 0 | For |
| Voya | 90,093 | 0 | 0 | 0 | For |
Showing the 25 largest of 121 asset managers. All 121 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
Description as filed by funds: To elect four nominees for director named below to hold office until the 2027 Annual General Meeting of Shareholders: Mark D. Smith, M.D.
JAZZ PHARMACEUTICALS PLC’s own tally for this item (“Elect Director: Mark D. Smith, M.D.”): 50,507,449 for, 3,685,604 against, per its Form 8-K filed July 26, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Each of the four nominees for director was elected as follows:”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 121 asset managers below reported 24,004,217 for, 258,347 against, 12,631 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,172,417 | 0 | 0 | 0 | For |
| BlackRock | 3,340,428 | 0 | 0 | 0 | For |
| Capital Group | 2,000,000 | 0 | 0 | 0 | For |
| Fidelity | 1,860,787 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 1,384,214 | 0 | 0 | 0 | For |
| JPMorgan | 1,142,041 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 949,636 | 0 | 0 | 0 | For |
| Dimensional | 723,171 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 587,263 | 0 | 0 | 0 | For |
| Capitol Series Trust | 529,982 | 0 | 0 | 0 | For |
| Pear Tree Funds | 512,200 | 0 | 0 | 0 | For |
| State Street | 495,031 | 0 | 0 | 0 | For |
| Charles Schwab | 451,732 | 0 | 0 | 0 | For |
| Transamerica | 378,261 | 0 | 0 | 0 | For |
| TIAA | 352,728 | 0 | 0 | 0 | For |
| First Trust | 231,775 | 0 | 0 | 0 | For |
| SEI | 224,419 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 211,351 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 200,541 | 0 | 0 | 0 | For |
| Federated Hermes | 192,148 | 0 | 0 | 0 | For |
| John Hancock | 160,308 | 0 | 0 | 0 | For |
| Jackson National | 141,257 | 0 | 0 | 0 | For |
| ETF Series Solutions | 125,584 | 0 | 0 | 0 | For |
| Equitable | 29,441 | 79,746 | 0 | 0 | Mixed |
| Voya | 90,093 | 0 | 0 | 0 | For |
Showing the 25 largest of 121 asset managers. All 121 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: To elect four nominees for director named below to hold office until the 2027 Annual General Meeting of Shareholders: Patrick Kennedy
JAZZ PHARMACEUTICALS PLC’s own tally for this item (“Elect Director: Patrick Kennedy”): 52,306,399 for, 1,901,706 against, per its Form 8-K filed July 26, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Each of the four nominees for director was elected as follows:”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 121 asset managers below reported 24,261,168 for, 1,396 against, 12,631 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,172,417 | 0 | 0 | 0 | For |
| BlackRock | 3,340,428 | 0 | 0 | 0 | For |
| Capital Group | 2,000,000 | 0 | 0 | 0 | For |
| Fidelity | 1,860,787 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 1,384,214 | 0 | 0 | 0 | For |
| JPMorgan | 1,142,041 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 949,636 | 0 | 0 | 0 | For |
| Dimensional | 723,171 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 587,263 | 0 | 0 | 0 | For |
| Capitol Series Trust | 529,982 | 0 | 0 | 0 | For |
| Pear Tree Funds | 512,200 | 0 | 0 | 0 | For |
| State Street | 495,031 | 0 | 0 | 0 | For |
| Charles Schwab | 451,732 | 0 | 0 | 0 | For |
| Transamerica | 378,261 | 0 | 0 | 0 | For |
| TIAA | 352,728 | 0 | 0 | 0 | For |
| First Trust | 231,775 | 0 | 0 | 0 | For |
| SEI | 224,419 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 211,351 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 200,541 | 0 | 0 | 0 | For |
| Federated Hermes | 192,148 | 0 | 0 | 0 | For |
| John Hancock | 160,308 | 0 | 0 | 0 | For |
| Jackson National | 141,257 | 0 | 0 | 0 | For |
| ETF Series Solutions | 125,584 | 0 | 0 | 0 | For |
| Equitable | 109,187 | 0 | 0 | 0 | For |
| Voya | 90,093 | 0 | 0 | 0 | For |
Showing the 25 largest of 121 asset managers. All 121 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
91% Approved · of votes cast
Description as filed by funds: To grant the Board of Directors authority under Irish law to allot and issue ordinary shares for cash without first offering those ordinary shares to existing shareholders pursuant to the statutory pre- emption right that would otherwise apply.
JAZZ PHARMACEUTICALS PLC’s own tally for this item (“5. To grant our board of directors authority under Irish law to allot and issue ordinary shares for cash without first offering those ordinary shares to existing shareholders pursuant to the statutory pre-emption right t”): 52,568,310 for, 5,308,898 against — passed, per its Form 8-K filed July 26, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “This proposal was approved as follows: Proposal 5 Proposal 5 was to grant our board of directors authority under Irish law to allot and issue ordinary shares for cash without first offering those ordinary shares to existing shareholders pursuant to the statutory pre-emption right that would otherwi…”
Support: 91% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of JAZZ PHARMACEUTICALS PLC’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Authorise Issue of Equity without Pre-emptive Rights” (2 managers, 36,717 for).
The 120 asset managers below reported 23,238,591 for, 999,887 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,172,417 | 0 | 0 | 0 | For |
| BlackRock | 3,340,428 | 0 | 0 | 0 | For |
| Capital Group | 2,000,000 | 0 | 0 | 0 | For |
| Fidelity | 1,860,787 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 1,384,214 | 0 | 0 | 0 | For |
| JPMorgan | 1,142,041 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 949,636 | 0 | 0 | Against |
| Dimensional | 723,171 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 587,263 | 0 | 0 | 0 | For |
| Capitol Series Trust | 529,982 | 0 | 0 | 0 | For |
| Pear Tree Funds | 512,200 | 0 | 0 | 0 | For |
| State Street | 495,031 | 0 | 0 | 0 | For |
| Charles Schwab | 451,732 | 0 | 0 | 0 | For |
| Transamerica | 378,261 | 0 | 0 | 0 | For |
| TIAA | 352,728 | 0 | 0 | 0 | For |
| First Trust | 231,775 | 0 | 0 | 0 | For |
| SEI | 224,419 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 211,351 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 200,541 | 0 | 0 | 0 | For |
| Federated Hermes | 192,148 | 0 | 0 | 0 | For |
| John Hancock | 160,308 | 0 | 0 | 0 | For |
| Jackson National | 141,257 | 0 | 0 | 0 | For |
| ETF Series Solutions | 125,584 | 0 | 0 | 0 | For |
| Equitable | 109,187 | 0 | 0 | 0 | For |
| Voya | 90,093 | 0 | 0 | 0 | For |
Showing the 25 largest of 120 asset managers. All 120 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
94% of fund votes cast · no official result
Description as filed by funds: To approve any motion to adjourn the Annual General Meeting, or any adjournments thereof, to another time and place to solicit additional proxies if there are insufficient votes at the time of the Annual General Meeting to approve Proposal 5.
The 119 asset managers below reported 22,738,906 for, 1,486,941 against, 12,631 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,172,417 | 0 | 0 | 0 | For |
| BlackRock | 3,340,428 | 0 | 0 | 0 | For |
| Capital Group | 2,000,000 | 0 | 0 | 0 | For |
| Fidelity | 1,860,787 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 1,384,214 | 0 | 0 | 0 | For |
| JPMorgan | 1,142,041 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 949,636 | 0 | 0 | Against |
| Dimensional | 723,171 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 587,263 | 0 | 0 | 0 | For |
| Capitol Series Trust | 529,982 | 0 | 0 | 0 | For |
| Pear Tree Funds | 512,200 | 0 | 0 | 0 | For |
| State Street | 0 | 495,031 | 0 | 0 | Against |
| Charles Schwab | 451,732 | 0 | 0 | 0 | For |
| Transamerica | 378,261 | 0 | 0 | 0 | For |
| TIAA | 352,728 | 0 | 0 | 0 | For |
| First Trust | 231,775 | 0 | 0 | 0 | For |
| SEI | 217,100 | 7,319 | 0 | 0 | For |
| Bridge Builder Trust | 211,351 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 200,541 | 0 | 0 | 0 | For |
| Federated Hermes | 192,148 | 0 | 0 | 0 | For |
| John Hancock | 160,308 | 0 | 0 | 0 | For |
| Jackson National | 141,257 | 0 | 0 | 0 | For |
| ETF Series Solutions | 125,584 | 0 | 0 | 0 | For |
| Equitable | 109,187 | 0 | 0 | 0 | For |
| Voya | 90,093 | 0 | 0 | 0 | For |
Showing the 25 largest of 119 asset managers. All 119 are in the interactive database (link above).
Combines 22 wordings of this item as funds reported it.
91% Approved · of votes cast
Description as filed by funds: To approve, on a non-binding advisory basis, the compensation of Jazz Pharmaceuticals plc's named executive officers, as disclosed in the proxy statement.
JAZZ PHARMACEUTICALS PLC’s own tally for this item (“3. To approve, on a non-binding advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement”): 49,319,464 for, 4,780,265 against — passed, per its Form 8-K filed July 26, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “This proposal was approved as follows:”
Support: 91% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,172,417 | 0 | 0 | 0 | For |
| BlackRock | 3,340,428 | 0 | 0 | 0 | For |
| Capital Group | 2,000,000 | 0 | 0 | 0 | For |
| Fidelity | 1,860,787 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 1,384,214 | 0 | 0 | 0 | For |
| JPMorgan | 1,142,041 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 949,636 | 0 | 0 | 0 | For |
| Dimensional | 723,171 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 587,263 | 0 | 0 | 0 | For |
| Capitol Series Trust | 529,982 | 0 | 0 | 0 | For |
| Pear Tree Funds | 512,200 | 0 | 0 | 0 | For |
| State Street | 495,031 | 0 | 0 | 0 | For |
| Charles Schwab | 451,732 | 0 | 0 | 0 | For |
| Transamerica | 378,261 | 0 | 0 | 0 | For |
| TIAA | 352,728 | 0 | 0 | 0 | For |
| First Trust | 231,775 | 0 | 0 | 0 | For |
| SEI | 224,419 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 211,351 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 200,541 | 0 | 0 | 0 | For |
| Federated Hermes | 192,148 | 0 | 0 | 0 | For |
| John Hancock | 160,308 | 0 | 0 | 0 | For |
| Jackson National | 141,257 | 0 | 0 | 0 | For |
| ETF Series Solutions | 0 | 125,584 | 0 | 0 | Against |
| Equitable | 109,187 | 0 | 0 | 0 | For |
| Voya | 90,093 | 0 | 0 | 0 | For |
Fund voting reports, all 120 managers: 24,083,392 for, 179,144 against, 12,631 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 3,144,775 | 501 | 0 | 0 | For |
| Capital Group | 2,020,672 | 0 | 0 | 0 | For |
| State Street | 2,005,318 | 0 | 0 | 0 | For |
| LSV ASSET MANAGEMENT | 1,652,873 | 0 | 0 | 0 | For |
| JPMorgan | 1,349,130 | 0 | 0 | 0 | For |
| Vestal Point Capital, LP | 1,339,717 | 0 | 0 | 0 | For |
| Baupost | 0 | 1,274,248 | 0 | 0 | Against |
| GEODE CAPITAL MANAGEMENT, LLC | 1,118,631 | 0 | 0 | 0 | For |
| Camber Capital Management LP | 1,116,047 | 0 | 0 | 0 | For |
| FRANKLIN ADVISERS INC | 1,065,951 | 0 | 0 | 0 | For |
| Swedbank Robur Fonder AB | 0 | 1,016,753 | 0 | 0 | Against |
| EcoR1 Capital, LLC | 1,013,952 | 0 | 0 | 0 | For |
| Fidelity | 932,101 | 0 | 0 | 0 | For |
| THOMPSON SIEGEL & WALMSLEY LLC | 619,062 | 0 | 0 | 0 | For |
| FULLER & THALER ASSET MANAGEMENT, INC. | 553,971 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 549,127 | 0 | 0 | 0 | For |
| Northern Trust | 528,215 | 0 | 0 | 0 | For |
| Charles Schwab | 455,551 | 0 | 0 | 0 | For |
| Polaris Capital Management, LLC | 453,660 | 0 | 0 | 0 | For |
| BNP Paribas Asset Management Holding S.A. | 0 | 407,082 | 0 | 0 | Against |
| Nuveen | 404,408 | 0 | 0 | 0 | For |
| Avidity Partners Management LP | 377,459 | 0 | 0 | 0 | For |
| John Hancock | 348,386 | 0 | 0 | 0 | For |
| GW&K Investment Management, LLC | 337,615 | 0 | 0 | 0 | For |
| Brandywine Global Investment Management, LLC | 316,721 | 0 | 0 | 0 | For |
Institutional-manager reports, all 439 managers: 29,792,765 for, 3,599,286 against, 142,874 abstained, 1,152 not voted, 101,034 1 year. Showing the 25 largest; every one is in the interactive database (link above).
Combines 11 wordings of this item as funds reported it.
100% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: To indicate, on a non-binding advisory basis, the preferred frequency of the advisory vote on the compensation of Jazz Pharmaceuticals plc's named executive officers.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| Capital Group | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| Pacer Funds Trust | 0 | 0 | 0 | 0 | -- |
| JPMorgan | 0 | 0 | 0 | 0 | -- |
| Columbia Threadneedle | 0 | 0 | 0 | 0 | -- |
| Dimensional | 0 | 0 | 0 | 0 | -- |
| FRANKLIN STRATEGIC SERIES | 0 | 0 | 0 | 0 | -- |
| Pear Tree Funds | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Transamerica | 0 | 0 | 0 | 0 | -- |
| TIAA | 0 | 0 | 0 | 0 | -- |
| First Trust | 0 | 0 | 0 | 0 | -- |
| SEI | 0 | 0 | 0 | 0 | -- |
| Bridge Builder Trust | 0 | 0 | 0 | 0 | -- |
| AIG/SunAmerica | 0 | 0 | 0 | 0 | -- |
| Federated Hermes | 0 | 0 | 0 | 0 | -- |
| John Hancock | 0 | 0 | 0 | 0 | -- |
| Jackson National | 0 | 0 | 0 | 0 | -- |
| ETF Series Solutions | 0 | 0 | 0 | 0 | -- |
| Equitable | 0 | 0 | 0 | 0 | -- |
| Voya | 0 | 0 | 0 | 0 | -- |
| American Century | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 117 managers: 22,122 for, 12,631 abstained, 22,861,201 1 year, 812,514 3 year. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 0 | 0 | 0 | 0 | -- |
| Capital Group | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| LSV ASSET MANAGEMENT | 0 | 0 | 0 | 0 | -- |
| Vestal Point Capital, LP | 0 | 0 | 0 | 0 | -- |
| Baupost | 0 | 0 | 0 | 0 | -- |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| Camber Capital Management LP | 0 | 0 | 0 | 0 | -- |
| FRANKLIN ADVISERS INC | 0 | 0 | 0 | 0 | -- |
| Swedbank Robur Fonder AB | 0 | 0 | 0 | 0 | -- |
| EcoR1 Capital, LLC | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| THOMPSON SIEGEL & WALMSLEY LLC | 0 | 0 | 0 | 0 | -- |
| FULLER & THALER ASSET MANAGEMENT, INC. | 0 | 0 | 0 | 0 | -- |
| MELLON INVESTMENTS Corp | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | Not Voted |
| Polaris Capital Management, LLC | 0 | 0 | 0 | 0 | -- |
| BNP Paribas Asset Management Holding S.A. | 0 | 0 | 0 | 0 | -- |
| Nuveen | 0 | 0 | 0 | 0 | -- |
| Avidity Partners Management LP | 0 | 0 | 0 | 0 | -- |
| John Hancock | 0 | 0 | 0 | 0 | -- |
| GW&K Investment Management, LLC | 0 | 0 | 0 | 0 | -- |
| Brandywine Global Investment Management, LLC | 0 | 0 | 0 | 0 | -- |
| Renaissance | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 410 managers: 205,050 for, 93,787 abstained, 1,152 not voted, 30,596,757 1 year, 238,613 3 year, 35,939 2 year. Showing the 25 largest; every one is in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
98% Approved · of votes cast
Description as filed by funds: To ratify, on a non-binding advisory basis, the appointment of KPMG as the independent auditors of Jazz Pharmaceuticals plc for the fiscal year ending December 31, 2024 and to authorize, in a binding vote, the Board of Directors, acting through the audit committee, to determine KPMG's remuneration.
JAZZ PHARMACEUTICALS PLC’s own tally for this item (“2. To ratify, on a non-binding advisory basis, the appointment of KPMG, Dublin as our independent auditors for the fiscal year ending December 31, 2024 and to authorize, in a binding vote, our board of directors, acting ”): 56,719,225 for, 1,184,200 against — passed, per its Form 8-K filed July 26, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “This proposal was approved as follows:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 124 asset managers below reported 24,112,197 for, 149,013 against, 13,987 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,172,417 | 0 | 0 | 0 | For |
| BlackRock | 3,340,428 | 0 | 0 | 0 | For |
| Capital Group | 2,000,000 | 0 | 0 | 0 | For |
| Fidelity | 1,860,787 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 1,384,214 | 0 | 0 | 0 | For |
| JPMorgan | 1,142,041 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 949,636 | 0 | 0 | 0 | For |
| Dimensional | 723,171 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 587,263 | 0 | 0 | 0 | For |
| Capitol Series Trust | 529,982 | 0 | 0 | 0 | For |
| Pear Tree Funds | 512,200 | 0 | 0 | 0 | For |
| State Street | 495,031 | 0 | 0 | 0 | For |
| Charles Schwab | 451,732 | 0 | 0 | 0 | For |
| Transamerica | 378,261 | 0 | 0 | 0 | For |
| TIAA | 352,728 | 0 | 0 | 0 | For |
| First Trust | 231,775 | 0 | 0 | 0 | For |
| SEI | 217,100 | 7,319 | 0 | 0 | For |
| Bridge Builder Trust | 211,351 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 200,541 | 0 | 0 | 0 | For |
| Federated Hermes | 192,148 | 0 | 0 | 0 | For |
| John Hancock | 160,308 | 0 | 0 | 0 | For |
| Jackson National | 141,257 | 0 | 0 | 0 | For |
| ETF Series Solutions | 0 | 125,584 | 0 | 0 | Against |
| Equitable | 109,187 | 0 | 0 | 0 | For |
| Voya | 90,093 | 0 | 0 | 0 | For |
Showing the 25 largest of 124 asset managers. All 124 are in the interactive database (link above).
Not shown here: this season’s fund filings also report 1 item from the meeting of July 24, 2025, which belongs to the 2025-2026 season. A meeting outside this season’s July 1 to June 30 window is not counted in this page’s items or in its totals of asset managers and fund votes.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 62,255,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 9.91% |
| 2 | BlackRock | 5.37% |
| 3 | Capital Group | 3.21% |
| 4 | Fidelity | 2.99% |
| 5 | Pacer Funds Trust | 2.22% |
| 6 | JPMorgan | 1.83% |
| 7 | Columbia Threadneedle | 1.53% |
| 8 | Dimensional | 1.16% |
| 9 | FRANKLIN STRATEGIC SERIES | 0.94% |
| 10 | Capitol Series Trust | 0.85% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 5.05% |
| 2 | Capital Group | 3.25% |
| 3 | State Street | 3.22% |
| 4 | LSV ASSET MANAGEMENT | 2.66% |
| 5 | JPMorgan | 2.17% |
| 6 | Vestal Point Capital, LP | 2.15% |
| 7 | Baupost | 2.05% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 1.80% |
| 9 | Camber Capital Management LP | 1.79% |
| 10 | FRANKLIN ADVISERS INC | 1.71% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Vanguard Group | 6,017,403 | 9.67% | Form 13F, quarter ended March 31, 2025 |
| BlackRock | 5,765,331 | 9.26% | Form 13F, quarter ended March 31, 2025 |
| Dimensional Fund Advisors | 2,328,430 | 3.74% | Form 13F, quarter ended March 31, 2025 |
| State Street | 1,966,590 | 3.16% | Form 13F, quarter ended March 31, 2025 |
| JPMorgan Chase | 1,662,042 | 2.67% | Form 13F, quarter ended March 31, 2025 |
| Seamus Mulligan | 1,299,546 | 2.09% | Proxy statement (DEF 14A), proxy filed June 6, 2025 |
| Renaissance Technologies | 1,044,574 | 1.68% | Form 13F, quarter ended March 31, 2025 |
| Bruce C. Cozadd | 849,462 | 1.36% | Proxy statement (DEF 14A), proxy filed June 6, 2025 |
| Morgan Stanley | 761,596 | 1.22% | Form 13F, quarter ended March 31, 2025 |
| FMR (Fidelity) | 761,502 | 1.22% | Form 13F, quarter ended March 31, 2025 |
Percentages above are of 62,255,000 shares outstanding, as reported by JAZZ PHARMACEUTICALS PLC on its Form 10-K dated December 31, 2023 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At JAZZ PHARMACEUTICALS PLC's shareholder meeting held July 25, 2024, in the 2024-2025 proxy season, 544 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 6,212 separate fund positions. Their filings are grouped here into 9 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on a non-binding advisory basis, the compensation of Jazz Pharmaceuticals plc's… — JAZZ PHARMACEUTICALS PLC's filing reports the proposal as approved, with 91% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: JAZZ PHARMACEUTICALS PLC's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on July 26, 2024.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from JAZZ PHARMACEUTICALS PLC’s 10-K dated December 31, 2023. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
JAZZ PHARMACEUTICALS PLC proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
Proxy Votes Now, “JAZZ PHARMACEUTICALS (JAZZ) 2024 Annual Meeting (2024-2025 season)”, https://proxyvotesnow.com/company/jazz-pharmaceuticals-plc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.